Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.23.2
Shareholders' Deficit (Tables)
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2022     16,970,120     $ 0.119  
Granted     -       -  
Shares vested     (2,000,000 )     0.021  
Non-vested, June 30, 2023     14,970,120     $ 0.132  
Schedule of Stock Option Activities Stock option activities for the six months ended June 30, 2023 are summarized as follows:
    Number of
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding, December 31, 2022     8,445,698     $ 0.40       3.43                -  
Exercised     -       -       -       -  
Balance Outstanding, June 30, 2023     8,445,698     $ 0.40       2.90     $ -  
Exercisable, June 30, 2023     8,445,698     $ 0.40       2.90     $ -  
Schedule of Warrant Activities Warrant activities for the six months ended June 30, 2023 are summarized as follows:
    Number of
Warrants		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding December 31, 2022     34,000,000     $ 0.011       3.73     $        -  
Granted     -       -       -       -  
Balance Outstanding June 30, 2023     34,000,000     $ 0.011       3.24     $ -  
Exercisable, June 30, 2023     34,000,000     $ 0.011       3.24     $ -